Wednesday, January 31, 2007

Palatin Looking Up

Palatin Technologies is looking up on news that AstraZeneca (AZN) has signed an obesity drug deal with Palatin Technologies (PTN). The deal could earn Palatin up to $300 million. Palatin is also developing an inhaled drug for sexual dysfunction for men and women. I mentioned this company a while back and I still feel strongly about this stock.

No comments: